17-alpha-hydroxyprogesterone has been researched along with Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, W; Cockrell, K; Granger, JP; Keiser, SD; LaMarca, B; Martin, JN; Parrish, MR; Ray, LF; Veillon, EW | 1 |
1 other study(ies) available for 17-alpha-hydroxyprogesterone and Ischemia
Article | Year |
---|---|
17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats.
Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Animals; Endothelin-1; Female; Hydroxyprogesterones; Ischemia; Placenta; Placental Circulation; Pregnancy; Progesterone Congeners; Rats; Tumor Necrosis Factor-alpha | 2009 |